Fulgent Genetics (FLGT) Retained Earnings (2015 - 2026)

Fulgent Genetics has reported Retained Earnings for 12 years, with the latest figure at $475.6 million in Q2 2026.

• Quarterly Retained Earnings fell 15.07% year-over-year to $475.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $475.6 million (down 15.07% YoY) and the FY2025 annual result came in at $530.0 million, down 10.25% from the prior year.
• Retained Earnings eased to $475.6 million in Q2 2026 per FLGT's latest filing, from $505.1 million in the prior quarter.
• Over five years, Retained Earnings peaked at $824.8 million in Q3 2022 and troughed at $475.6 million in Q2 2026.
• A 5-year average of $657.5 million and a median of $615.4 million in 2024 frame the typical range for Retained Earnings.
• The sharpest annual moves came in 2022 and 2024: Retained Earnings jumped 90204.4% in 2022, then dropped 21.67% in 2024.
• Over 5 years, Retained Earnings stood at $801.0 million in 2022, then slipped by 20.95% to $633.2 million in 2023, then retreated by 6.75% to $590.5 million in 2024, then declined by 10.25% to $530.0 million in 2025, then slipped by 10.26% to $475.6 million in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered $475.6 million, $505.1 million, and $530.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.